WNT5A and Ewing sarcoma: To confirm that there was no significant activation of the canonical, beta-catenin-dependent signaling pathway by recombinant Wnt5a in Ewing sarcoma cell lines, we performed a TOPFlash assay for beta-catenin-dependent transcriptional activity (Figure 1D).